Latest insights on genetic testing related hearing loss

According to the World Health Organization (WHO), approximately 2.5 billion people worldwide are estimated to have some ...

February 9, 2024 | Friday | Analysis
Korean startup C-Biomex announces oncology research partnership with US-based MD Anderson

The University of Texas MD Anderson Cancer Center in the US, and South Korea-based startup C-Biomex have announced ...

February 12, 2024 | Monday | News
Australia's Recce partners Indonesia's Etana Biotech to advance anti-infective R&D, manufacturing 

Recce Pharmaceuticals Limited, the Company developing a New Class of Synthetic Anti-Infectives, has signed Memorand...

February 8, 2024 | Thursday | News
Harnessing AI’s Potential for a Revolution in Cancer Screening

Imagine a world where a non-invasive breast cancer test delivers results within 15 minutes, costing less than half the p...

February 7, 2024 | Wednesday | Analysis
Empowering Lives: Rare Disease Diagnostics and Awareness

Rare diseases, often overlooked, affect a significant portion of the global population. However, early detection and int...

February 7, 2024 | Wednesday | Analysis
Sysmex and Hitachi High-Tech to collaboratively develop New Genetic Testing Systems

Sysmex Corporation and Hitachi High-Tech Corporation are collaborating to develop novel genetic testing systems based on...

February 8, 2024 | Thursday | News
AstraZeneca expands US manufacturing footprint to accelerate next-gen cell therapy development

AstraZeneca is investing $300 million in a state-of-the-art facility in Rockville, MD to launch its life-saving cell the...

February 7, 2024 | Wednesday | News
Australian government invests $20 M to find new therapies for childhood brain cancers

The Australian government is funding a wide-ranging national research programme that will give new hope and help to Aust...

February 5, 2024 | Monday | News
Singapore develops new and precise way to treat most common type of brain cancer

Researchers led by Nanyang Technological University, Singapore (NTU Singapore) have developed a new and precise way to t...

February 2, 2024 | Friday | News
Experts advocate HPV Vaccination Programmes for Gynaecologic Cancer prevention in MENA region

The 16th Obstetrics and Gynaecology Conference took place on 30 January under the theme ‘From evidence to practice...

January 30, 2024 | Tuesday | Opinion
Breakthroughs in Rare Diseases Therapeutics

The previous year witnessed many promising developments in the fight against rare diseases. The recent Casgevy’s F...

February 1, 2024 | Thursday | Analysis
Trailblazing Impact of Antibody-Drug Conjugates

The field of Antibody-Drug Conjugates (ADCs) has experienced a remarkable transformation, shifting from dormancy to a su...

February 1, 2024 | Thursday | Opinion
Next-Gen ADCs as Precision Weapon Against Cancer

Cancer poses a significant challenge for the pharmaceutical industry, driving a constant search for improved oncology dr...

February 1, 2024 | Thursday | Analysis
Study in Hong Kong sparks new therapeutic target for lung cancer

Lung cancer is the leading cause of cancer deaths in Hong Kong and worldwide, but there is still an unmet clinical need ...

January 30, 2024 | Tuesday | News
AbbVie expands Biologics Manufacturing Capacity with $223 M investment at Singapore Site 

AbbVie expanded its Singapore manufacturing facility on 25th Jan, strengthening its manufacturing capabilities. With a n...

January 25, 2024 | Thursday | Company results
New approaches to treat diverse bile duct cancers prevalent in Southeast Asia

An international study led by the National Cancer Centre Singapore (NCCS) and Duke-NUS Medical School has effectively ta...

January 24, 2024 | Wednesday | News
Singapore paves way for therapies to maintain mental well-being of ageing individual

A team of scientists from Nanyang Technological University, Singapore (NTU Singapore) has demonstrated that commun...

January 22, 2024 | Monday | News
Molecular Diagnostics may offer Hope for Cancer Drug Shortages in Asia

Projections by the International Agency for Research on Cancer estimate 15.1 million new cases per year, until 2040. Thi...

January 19, 2024 | Friday | Opinion

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls